🔎 Trials Near Me

Home › Skin Conditions › NCT07033169

A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis

RecruitingObservational study

A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis of Commonly Encountered Dermatologic Diseases

Who can join

Ages 10 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Patient must present to an Advocate Health dermatology clinic
* Patient must have the ability and willingness to provide informed consent and comply with study procedures and visits
* Participant dermatologists must have access to the required technology (e.g., smartphone with internet access) and be capable of using it for the required image capture

Exclusion Criteria:

* Patients who are unable to comply with study procedures due to physical or mental health limitations (as assessed by study coordinator)
* Pediatric, adolescent, and teen patients who present with dermatological conditions on their genitalia will not be included in the study (in support of patient privacy concerns).

About the study

Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will be de-identified. The software will not have any unique identifiers of participants saved in the system. The photos will be named based on participant enrollment numbers or unique code numbers and no unique identifiers will be attached to the photos. There will be no data collection form necessary for this study

Sponsor: Wake Forest University Health Sciences · Participants: 400 · Started: Sep 15, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07033169

Locations in the U.S.

North CarolinaWake Forest University Health Sciences Department of Dermatology, Winston-Salem

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.